South Korean Stocks Post Best Day in Eight Weeks as Virus Worries Cap Gains

A rebound with limits attached
South Korean shares climbed Monday, but the virus and U.S. inflation worries held the gains back.
Mark

So stocks are up, but the story says gains were capped. Capped by what?

Mimi

Two things. Record COVID-19 numbers at home, with 1,100 new cases reported for Sunday and Seoul's strictest curbs starting Monday, and nerves about U.S. inflation data coming Tuesday.

Mark

Why would American inflation matter to Seoul's market?

Mimi

It feeds expectations about how fast the Federal Reserve tightens policy. Powell testifies from Wednesday, so investors are waiting on that.

Luke

Careful with the word 'best.' The report says the index was on track for its biggest jump in nearly eight weeks, measured at 0220 GMT, mid-session. It isn't a closing figure.

Mimi

Fair. The 0.89% gain is where the index stood at that moment, and it follows a 1.07% drop on Friday, so part of this is a bounce.

Mark

Foreigners were net buyers. Is that a signal?

Luke

It's 10.4 billion won, about $9 million. That's a small figure, and the report doesn't say what drove it, so I wouldn't read much into it.

Mark

What about the export numbers?

Mimi

Up 14.1% year on year for July 1-10, but that's well below June's 40.8% for the same stretch.

Luke

And ten days is a short window. The source doesn't say whether it's a real slowdown or a timing quirk, so that's unknown.

Mark

So what's the takeaway?

Mimi

A cautious rebound, with the next real test coming from U.S. data this week.

  • The KOSPI climbed 0.89% to 3,246.51, its strongest session in nearly eight weeks, but the gain is tethered to a day of hesitation.
  • Seoul's toughest anti-COVID restrictions took effect Monday as the country faced its worst outbreak yet, with 1,100 new cases reported for Sunday.
  • Export growth slowed sharply to 14.1% for the first ten days of July, down from a 40.8% surge in early June, unsettling hopes for a quick recovery.
  • Investors are bracing for Tuesday's U.S. consumer price figures and Fed Chair Powell's testimony, which could signal how fast policy will tighten.
  • Foreign buyers stepped in, and the won firmed to 1,146.7 per dollar, suggesting cautious confidence rather than outright relief.

On a Monday in July 2021, South Korea's main stock index edged upward, recovering from a weak Friday, yet its climb was held in check by a surge of coronavirus infections and the strictest curbs yet imposed in Seoul. It is the kind of modest rebound that markets have learned to read with suspicion, as investors weigh a sturdy export sector against a public health emergency and the distant but looming question of American inflation. Whether this brief optimism endures depends less on Seoul's streets than on the data and words coming out of Washington later in the week.

By early Monday morning in Seoul, the KOSPI had climbed to 3,246.51, a gain of nearly one percent that promised the best session in about eight weeks. It came as a welcome reversal after Friday's slide of more than one percent, and foreign investors were quietly net buyers, a small sign of faith in the market.

Yet the rebound was tightly bounded. Seoul's toughest anti-COVID restrictions took effect that same day, meant to contain the worst outbreak the country had yet faced, after 1,100 new cases were reported for Sunday alone. Shoppers, workers, and businesses were bracing for tighter daily life even as stocks ticked upward.

The economy showed both strength and strain. Exports for the first ten days of July were up 14.1% on a year earlier, a healthy figure, though it marked a sharp slowdown from the 40.8% surge seen in early June. Chipmakers Samsung Electronics and SK Hynix edged higher, while the won firmed modestly against the dollar and government bond yields dipped.

All eyes now turned west. Tuesday's U.S. consumer price data and Federal Reserve Chair Jerome Powell's testimony would reveal how quickly the Fed might tighten policy. For now, Seoul's investors were holding their breath, hoping Monday's modest gains could survive the week ahead.

By 0220 GMT on Monday, July 12, the KOSPI stood at 3,246.51, up 28.56 points, or 0.89%, and on course for its largest one-day gain since May 18. That would make it the best session in nearly eight weeks for South Korean shares. It also followed a rough Friday, when the benchmark index fell 1.07%.

The rebound came with limits attached. Two things held back the gains: a surge in COVID-19 cases at home and caution ahead of U.S. inflation data due later in the week.

The virus news was concrete. The country's toughest anti-COVID-19 restrictions took effect in Seoul on Monday, aimed at containing what has become its worst outbreak so far. South Korea reported 1,100 new cases for Sunday.

Among the large-cap names, technology giant Samsung Electronics rose 0.50%, and its chip-making peer SK Hynix gained 1.26%. LG Chem climbed 0.84% and Naver rose 0.36%. Foreign investors were net buyers on the main board, purchasing 10.4 billion won, about $9.09 million, worth of shares.

Trade data offered a mixed reading. According to customs agency figures, South Korean exports for the first ten days of July rose 14.1% from a year earlier. That is a clear gain, but a marked slowdown from the 40.8% surge recorded for June 1-10.

Currency and bond markets moved in step with equities. The won firmed 0.21% to 1,146.7 per dollar on the onshore settlement platform. Offshore, it was quoted at 1,145.9, and the one-month non-deliverable forward contract stood at 1,145.8. In debt markets, September futures on three-year treasury bonds rose 0.05 point to 110.37, while the yield on the most liquid three-year Korean treasury bond fell 1.1 basis points to 1.364%.

The week's attention now turns to Washington. Tuesday brings U.S. consumer price data, and Federal Reserve Chair Jerome Powell testifies starting Wednesday. Investors are focused on the inflation outlook and how quickly the Fed might tighten policy, questions that will shape whether Monday's gains hold.

Quieres la nota completa? Lee el original en Reuters ↗
Contáctanos FAQ